Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -18.92% vs 103.44% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 47.99% vs 23.21% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -11.46% vs 54.16% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -2.88% vs 395.24% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Tibet Rhodiola Pharmaceutical Holding Co. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -18.92% vs 103.44% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 1.60% vs 2.12% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 47.99% vs 23.21% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 4.66% vs -14.28% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -11.46% vs 54.16% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -20.24% vs 4.82% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -2.88% vs 395.24% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






